Item 8.01. Other Events
On August 25, 2022, Isleworth Healthcare Acquisition Corp. (the "Company" or
"we") issued a press release announcing that we cancelled our special meeting of
shareholders that was previously scheduled for August 26, 2022, and that we will
redeem all of our outstanding shares of common stock that were included in the
units issued in its initial public offering (the "public shares"), effective as
of the close of business on August 29, 2022, as the Company will not consummate
an initial business combination on or prior to September 1, 2022. We have
furnished herewith as Exhibit 99.1 a copy of the press release.
Forward-Looking Statements
Certain information contained in this press release may be deemed to constitute
forward-looking statements within the meaning of the "safe harbor" provisions of
the Private Securities Litigation Reform Act of 1995. These forward-looking
statements relate to expectations or forecasts for future events, including,
without limitation, the redemption of the Company's public shares and the
Company's subsequent dissolution and liquidation and its delisting from the
Nasdaq Stock Exchange and its termination of registration with the Commission.
These statements may be preceded by, followed by or include the words "may,"
"might," "will," "will likely result," "should," "estimate," "plan," "project,"
"forecast," "intend," "expect," "anticipate," "believe," "seek," "continue,"
"target" or similar expressions. Such statements are subject to certain risks
and uncertainties that could cause our actual results in the future to differ
materially from the Company's historical results and those presently anticipated
or projected. The Company wishes to caution investors not to place undue
reliance on any such forward-looking statements. Any forward-looking statements
speak only as of the date on which such statements are made, and the Company
undertakes no obligation to update such statements to reflect events or
circumstances arising after such date. The Company assumes no obligation to
update forward-looking statements except to the extent required by applicable
securities laws. If the Company does update one or more forward-looking
statements, no inference should be drawn that the Company will make additional
updates with respect to those or other forward-looking statements.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
No. Description
99.1 Press Release, dated August 25, 2022
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses